Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
BMC Medical Genomics|April 30, 2008
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisAdam I Riker, Steven A Enkemann, Oystein Fodstad, et al.
Molecular & Cellular Proteomics : MCP|December 22, 2022
Native Size-Exclusion Chromatography-Based Mass Spectrometry Reveals New Components of the Early Heat Shock Protein 90 Inhibition Response Among Limited Global ChangesRahul S Samant, Silvia Batista, Mark Larance, et al.
Cancer Immunology Research|April 14, 2023
Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast CancerDominique C Hinshaw, Gloria A Benavides, Brandon J Metge, et al.
Molecular Cancer|September 2, 2014
microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancerJack W Rostas, Hawley C Pruitt, Brandon J Metge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast CancerAditya Bardia, Shanu Modi, Mafalda Oliveira, et al.
Cell Death & Disease|July 6, 2026
Disrupting Treg lineage stability elicits RORgT-mediated plasticity and enhances anti-tumor immunityCourtney A Swain, Dominique C Hinshaw, Ian D Miranda, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2017
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple MyelomaMeera Mohan, Rohan S Samant, Donghoon Yoon, et al.
Oncotarget|November 27, 2016
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Oncotarget|May 4, 2018
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Cancer Research|July 22, 2021
Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated MacrophagesDominique C Hinshaw, Ann Hanna, Tshering Lama-Sherpa, et al.
Pageof 21